• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎链球菌性肺炎致呼吸衰竭的危险因素:肺炎链球菌血清型的重要性。

Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes.

机构信息

Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona.

出版信息

Eur Respir J. 2014 Feb;43(2):545-53. doi: 10.1183/09031936.00050413. Epub 2013 Jul 11.

DOI:10.1183/09031936.00050413
PMID:23845720
Abstract

Pneumococcal serotypes are one of the main determinants of pneumococcal disease severity; however, data about their implication in respiratory failure are scarce. We conducted an observational study of adults hospitalised with invasive pneumococcal pneumonia to describe the host- and pathogen-related factors associated with respiratory failure. Of 1258 adults with invasive pneumococcal disease, 615 (48.9%) had respiratory failure at presentation. Patients with respiratory failure were older (62.1 years versus 55.4 years, p<0.001) and had a greater proportion of comorbid conditions. They also had a greater proportion of septic shock (41.7% versus 6.1%, p<0.001), required admission to the intensive care unit more often (38.4% versus 4.2%, p<0.001) and had a higher mortality (25.5% versus 3.5%, p<0.001). After adjustment, independent risk factors for respiratory failure were: age >50 years (OR 1.63, 95% CI 1.15-2.3), chronic lung disease (OR 1.54, 95% CI 1.1-2.15), chronic heart disease (OR 1.49, 95% CI 1.01-2.22) and infection caused by serotypes 3 (OR 1.97, 95% CI 1.23-3.16), 19A (OR 2.34, 95% CI 1.14-4.42) and 19F (OR 3.55, 95% CI 1.22-10.28). In conclusion, respiratory failure is a frequent complication of pneumococcal pneumonia and causes high morbidity and mortality. Pneumococcal serotypes 3, 19A and 19F are the main risk factors for this complication.

摘要

肺炎球菌血清型是肺炎球菌疾病严重程度的主要决定因素之一;然而,关于其与呼吸衰竭关系的数据却很少。我们对因侵袭性肺炎球菌性肺炎住院的成年人进行了一项观察性研究,以描述与呼吸衰竭相关的宿主和病原体相关因素。在 1258 名患有侵袭性肺炎球菌病的成年人中,615 名(48.9%)在就诊时出现呼吸衰竭。有呼吸衰竭的患者年龄较大(62.1 岁与 55.4 岁,p<0.001),合并症比例较高。他们也有更高比例的感染性休克(41.7%与 6.1%,p<0.001),更经常需要入住重症监护病房(38.4%与 4.2%,p<0.001),死亡率更高(25.5%与 3.5%,p<0.001)。调整后,呼吸衰竭的独立危险因素为:年龄>50 岁(OR 1.63,95%CI 1.15-2.3)、慢性肺部疾病(OR 1.54,95%CI 1.1-2.15)、慢性心脏病(OR 1.49,95%CI 1.01-2.22)和由血清型 3(OR 1.97,95%CI 1.23-3.16)、19A(OR 2.34,95%CI 1.14-4.42)和 19F(OR 3.55,95%CI 1.22-10.28)引起的感染。总之,呼吸衰竭是肺炎球菌性肺炎的常见并发症,可导致高发病率和死亡率。血清型 3、19A 和 19F 是这种并发症的主要危险因素。

相似文献

1
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes.肺炎链球菌性肺炎致呼吸衰竭的危险因素:肺炎链球菌血清型的重要性。
Eur Respir J. 2014 Feb;43(2):545-53. doi: 10.1183/09031936.00050413. Epub 2013 Jul 11.
2
Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia.非疫苗型肺炎球菌血清型的出现对侵袭性肺炎球菌性肺炎成人患者的临床表现和结局的影响。
Clin Microbiol Infect. 2013 Apr;19(4):385-91. doi: 10.1111/j.1469-0691.2012.03895.x. Epub 2012 May 14.
3
Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes.肺炎链球菌性肺炎合并感染性休克:宿主和病原体相关因素及预后。
Thorax. 2010 Jan;65(1):77-81. doi: 10.1136/thx.2009.123612. Epub 2009 Dec 8.
4
Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia.肺炎链球菌血清型群对菌血症性肺炎成人患者结局的影响。
Eur Respir J. 2010 Nov;36(5):1073-9. doi: 10.1183/09031936.00176309. Epub 2010 Feb 11.
5
Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.肺炎链球菌性社区获得性肺炎的肺部并发症:发生率、预测因素和结局。
Clin Microbiol Infect. 2012 Nov;18(11):1134-42. doi: 10.1111/j.1469-0691.2011.03692.x. Epub 2011 Nov 1.
6
Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.2009-2012 年引起侵袭性肺炎球菌病的肺炎链球菌的荚膜血清型和抗菌药物敏感性,重点关注菌血症性肺炎和脓胸的 19A 血清型以及β-内酰胺类药物耐药性。
Int J Antimicrob Agents. 2013 Nov;42(5):395-402. doi: 10.1016/j.ijantimicag.2013.07.017. Epub 2013 Sep 6.
7
[Pneumococcal pneumonia in the era of heptavalent pneumococcal conjugate vaccine].[七价肺炎球菌结合疫苗时代的肺炎球菌肺炎]
Enferm Infecc Microbiol Clin. 2011 Apr;29(4):250-6. doi: 10.1016/j.eimc.2010.09.014. Epub 2011 Feb 20.
8
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia.成人因侵袭性和非侵袭性社区获得性肺炎住院的血清型流行情况。
Thorax. 2012 Jun;67(6):540-5. doi: 10.1136/thoraxjnl-2011-201092. Epub 2012 Feb 28.
9
Serotypeº1 [corrected] childhood invasive pneumococcal disease has unique characteristics compared to disease caused by other streptococcus pneumoniae serotypes.血清型 1[更正] 儿童侵袭性肺炎球菌病与其他肺炎链球菌血清型引起的疾病相比具有独特的特征。
Pediatr Infect Dis J. 2013 Jun;32(6):614-8. doi: 10.1097/INF.0b013e31828691cb.
10
Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia.七价结合疫苗型肺炎球菌性肺炎成人患者的临床特征。
Vaccine. 2014 Mar 14;32(13):1460-5. doi: 10.1016/j.vaccine.2014.01.035. Epub 2014 Feb 7.

引用本文的文献

1
Severe Invasive Pneumococcal Infection With Multiple Abscesses Caused by a Less Virulent Serotype 1 Pneumococcus: A Case Report.由低毒力1型肺炎球菌引起的伴有多发性脓肿的严重侵袭性肺炎球菌感染:一例报告
Cureus. 2025 Feb 21;17(2):e79398. doi: 10.7759/cureus.79398. eCollection 2025 Feb.
2
Infectious Foci, Comorbidities and Its Influence on the Outcomes of Septic Critically Ill Patients.感染灶、合并症及其对脓毒症危重症患者预后的影响
Microorganisms. 2024 Aug 18;12(8):1705. doi: 10.3390/microorganisms12081705.
3
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21.
加拿大血和呼吸道标本中肺炎链球菌 3 型分离株的表型和分子特征:CANWARD 2007-21。
J Antimicrob Chemother. 2024 Oct 1;79(10):2653-2661. doi: 10.1093/jac/dkae272.
4
Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials.重症社区获得性肺炎中的类固醇:危险、无用还是神奇疗法?临床试验的过山车。
Anaesth Crit Care Pain Med. 2023 Aug;42(4):101253. doi: 10.1016/j.accpm.2023.101253. Epub 2023 May 26.
5
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors.评估 15 价肺炎球菌结合疫苗 V114 的安全性、耐受性和免疫原性的 3 期临床试验,随后在高危成年人中(年龄 18-49 岁)在 6 个月后接种 23 价肺炎球菌多糖疫苗(PNEU-DAY):基于基线风险因素的亚组分析。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2177066. doi: 10.1080/21645515.2023.2177066. Epub 2023 Mar 2.
6
Invasive Pneumococcal Disease Characterization in Adults and Subgroups aged < 60 years and ≥ 60 years in Bogota, Colombia.哥伦比亚波哥大60岁及以上和60岁以下成年人及亚组侵入性肺炎球菌疾病特征
IJID Reg. 2022 Apr 28;3:293-299. doi: 10.1016/j.ijregi.2022.04.007. eCollection 2022 Jun.
7
Bacteremic pneumococcal pneumonia: arrhythmogenic disease.菌血症性肺炎球菌肺炎:致心律失常性疾病。
Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):111-113. doi: 10.37201/req/s01.23.2022. Epub 2022 Apr 22.
8
Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY).V114(一种15价肺炎球菌结合疫苗)在18至49岁有或无肺炎球菌疾病风险因素的免疫功能正常成年人中的免疫原性、安全性和耐受性:一项随机3期试验(PNEU-DAY)
Open Forum Infect Dis. 2021 Dec 18;9(3):ofab605. doi: 10.1093/ofid/ofab605. eCollection 2022 Mar.
9
Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance.肺炎与侵袭性肺炎球菌疾病:肺炎球菌结合疫苗在多重耐药时代的作用
Vaccines (Basel). 2021 Apr 22;9(5):420. doi: 10.3390/vaccines9050420.
10
Pediatric bacterial meningitis and meningococcal disease profile in a Brazilian General Hospital.巴西一家综合医院小儿细菌性脑膜炎和脑膜炎球菌病概况。
Braz J Infect Dis. 2020 Jul-Aug;24(4):337-342. doi: 10.1016/j.bjid.2020.06.001. Epub 2020 Jun 26.